Introduction
According to the World Health Organization (WHO), depression was ranked as the third leading cause of the global burden of disease in 2004 and will move into the first place by 2030. Worldwide, the fifth contributor to the burden of disease in 2020 is predicted to be COPD. 1, 2 As defined by American Thoracic Society (ATS) and European Respiratory Society (ERS), COPD is a preventable and treatable disease state characterized by airflow limitation that is not fully reversible. The airflow limitation is usually progressive and is associated with an abnormal inflammatory response of the lungs to noxious particles or gases, primarily caused by cigarette smoking. It consists of the association of chronic bronchitis and emphysema. Chronic bronchitis is defined clinically as chronic productive cough for 3 months in each of 2 successive years in a patient in whom other causes of productive chronic cough have been excluded. Emphysema is defined pathologically as the presence of permanent enlargement of the airspaces distal to the terminal bronchioles, accompanied by destruction of their walls and without obvious fibrosis.
Several clinical studies show high rates of anxiety (21%-96%) 4 and affective (mostly depressive) disorders (27%-79%) in COPD, 5, 6 which can affect prognostic evolution in terms of compliance, disability, and mortality. 7 It is not easy to diagnose depression in COPD patients because of overlapping symptoms between COPD and depression. Severe COPD could lead to somatic symptoms that are difficult to distinguish from depressive symptoms: eg, change in appetite/weight versus tearfulness/depressed appearance; sleep disturbances versus social withdrawal; fatigue or loss of energy versus brooding/pessimism; and diminished ability to think or concentrate versus lack of reactivity to environmental events. The validity of the International Classification of Diseases (ICD)-10 and Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria for depression, in fact, may to a certain degree be questioned, because it is difficult to decide when somatic symptoms are secondary to depression and when they are secondary to COPD. 8 Additional variables that have potential to confound the association between COPD and depression regard some common risk factors, including the subject's demographic characteristics (age, sex, race/ethnicity, and marital status), education, body mass index (BMI), alcohol consumption, tobacco use, socioeconomic status (income), respiratory symptoms (dyspnea and difficulty with walking), and comorbid chronic conditions such as heart disease, stroke, diabetes, arthritis, hypertension, congestive heart failure, and cancer. 9 The nature of the relationship between COPD and depression is not clear. However, it is well documented that depressed patients show a markedly elevated rate of cigarette smoking, 10 which is the most important risk factor for COPD. It has been also postulated that (mild) hypoxia -that is also present in COPD patients -can induce central neurobiological changes that predispose to depression and suicide. 11 Furthermore, in a study with a large sample, a relevant percentage of COPD patients entering pulmonary rehabilitation experienced clinically relevant symptoms of anxiety and depression. 12 However, it could be supposed that both COPD and depression are the clinical manifestations of a common underlying pathophysiologic process. Indeed, data in the literature show that COPD and depression might not be "comorbid" conditions per se, but rather both are pathophysiologically related with a common substrate. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] Some authors suggest considering COPD as a "chronic systemic inflammatory syndrome" rather than a respiratory disease associated with extrapulmonary symptoms (including neurocognitive deficits, depression, anxiety, sleep disturbance, and other non-mental chronic disorders, such as coronary and peripheral artery diseases, anemia, osteoporosis, and rheumatoid arthritis).
14 Some characteristics commonly observed in COPD patients, like obesity, 27 are indeed associated with inflammation processes related to depression and anxiety, 28 suggesting a complex bidirectional association between adiposity and depression. 26 In this field, as suggested by some authors, the reduction of adiposity through physical exercise seems related to significant changes in depressive symptoms. 29 As a consequence, ATS and ERS guidelines have emphasized the importance of pulmonary rehabilitation for patients with COPD. 30 Several authors have indeed shown that there is a strong correlation among physical activity, adiposity, and mental health: several data have suggested that aerobic exercise shows significant effects, comparable to pharmacotherapy [31] [32] [33] and to psychotherapy, 34 on reducing depressive symptomatology. 35 Coventry et al specifically demonstrated that structured exercise training significantly reduces both symptoms of depression and anxiety in people with COPD; furthermore, they showed that structured exercise training is more effective than other, complex psychological, behavioral and lifestyle interventions previously thought to improve mental health in people with COPD. 36 Pulmonary rehabilitation shows poor effects on lung physiology (eg, ventilation parameters); nevertheless, it improves dyspnea, performance, anxiety, depressive symptoms, and quality of life (QoL). [37] [38] [39] [40] [41] [42] It also seems to decrease secretory function of adipocytes, resulting in reduction of their volume measured through fat mass. 43 In this regard, although BMI is widely used as an indirect parameter to assess adiposity, it has been demonstrated that BMI would have a poor correlation with fat mass, which probably represents a more accurate measure. 43 Considering the impact of aerobic exercise on anxious and depressive symptomatology, physical performance, QoL, and adiposity (assessed with BMI and fat mass), the primary aim of this study was to evaluate the effects of aerobic exercise, proposed in the context of pulmonary rehabilitation, through the correlation of psychopathological variables (depressive and anxious symptoms) and physical/ pneumological parameters. The secondary endpoint regards the evaluation of potential improvement in QoL and in cognitive performance. 
Materials and methods
This prospective cohort study was carried out in pneumology and psychiatry wards in the University Hospital PoliclinicoVittorio Emanuele of Catania, Italy from January to June 2012. The study was approved by the local ethical committee of the Policlinico "G. Rodolico" University Hospital, in accordance with the code of ethics of the World Medical Association, and written informed consent was obtained by all participants.
Inclusion criteria were diagnosis of COPD and eligibility to perform pulmonary rehabilitation, according to ATS and ERS guidelines. 44 Exclusion criteria were indication for restoring treatment of airway patency and current psychopharmacological treatment (including sleeping pills).
Fifty-two consecutive subjects (46 males and six females) were enrolled, with a mean age of 71.5±6.29 years and a mean school education of 8.08±3.21 years.
Enrolled patients started a 6-week rehabilitation protocol, consisting of lower limb/limbs (treadmill and exercise bike) and upper art (arm ergometer Davenbike ® ) training, as well as calisthenic exercises with increasing intensity from a minimum of 80% to a maximum workload for lower arts in a minimum time.
As proposed by the lung specialists in the pneumology ward of our university hospital, training sessions went on for 2 hours over 5 days a week and were supervised by two physiotherapists and a lung specialist. To exclude potential bias, no change in diet regime was carried out during the full duration of the trial.
Patients were evaluated at first access to pulmonary rehabilitation outpatient wards in order to assess inclusion and exclusion criteria.
For eligible patients, psychometric assessment, completion of the preliminary investigation, and admission in the rehabilitation program were performed. The assessment, measured both at baseline and at the end of the 3-month rehabilitation program, consisted of spirometry with bronchodilator test, walking test (6- According to the HAM-D score (cutoff =8), the total sample was divided into two subgroups: depression-positive (D) and depression-negative (ND) subjects.
Continuous variables were compared using the Student's t-test and the Mann-Whitney U-test. Correlations were evaluated using Spearman's coefficient. Categorical variables were compared by chi-square test. A two-tailed test was used to assess statistical significance; a P-value of 0.05 was considered significant and a P-value of 0.01 was considered highly significant. Statistical analysis was performed using the Intercooled Stata 8 for Windows software (StataCorp LP, College Station, TX, USA).
Results
The descriptive analysis of psychometric and pneumological parameters at baseline and at the end of the rehabilitation program (at the end of month 3) are presented in Table 1 .
Data show that improvement in all pneumological and respiratory parameters was statistically significant, except for Tiffeneau index.
The sample was divided into two subgroups consisting of 38 D and 14 ND subjects according to HAM-D.
The mean and standard deviation of psychometric and pneumological parameters at baseline and month 3 in both patient subgroups are shown in Table 2 . We did not find a statically significant difference between the two subgroups in age, lung function, and baseline body composition.
Regarding the mean BMI at baseline, the D subgroup was overweight (24/38 patients, =63%, had a mean BMI 28.37±6.80) and the ND subgroup was normal weight (4/14 patients, =28%, had a mean BMI 24.96±4.1) (Figures 1 and 2 ), according to WHO criteria, 45 even if the absolute difference in BMI between the two subgroups was not statistically significant. Pneumological and psychological parameters overlapped except for HAM-D (P=0.002), HADS-A (P=0.03), SCL-90 (P=0.02), and TMT-A (P=0.02): these differences disappeared at 3 months. At baseline 73% of subjects (38/52) exceeded the cutoff for depression on the HAM-D (D subgroup). At month 3, the rate of D subjects was reduced from 73% to 7.7% (4/52, odds ratio 6.6, P=0.0002). The improvement in almost all other psychological and medical/ pneumological parameters was also significant both in the D and ND subgroups at the end of the study.
We compared reported differences following the rehabilitation treatment between the D and ND subgroups Table 1 Descriptive and paired comparison analysis of psychometric and pneumological parameters at baseline and at 3 months in the total sample of patients with COPD in a pulmonary rehabilitation program Table 3) . A significant correlation between psychometric (in particular, HADS-A, HADS-D, STAI-2, SCL-90, TMT-B, TMT-BA, and CPM) and internistic parameters was found, especially with fat mass and BMI in the total population: the reduction in fat mass and BMI was related to decreased anxiety and depression and improved QoL and cognitive performance (Tables 4 and 5 ; Figures 3-6) .
At baseline in group D, a significant correlation was present between BMI and the following psychometric (Tables 4  and 5 ; Figures 5 and 6 ). These correlations were not statistically significant in subgroup ND.
A significant correlation between BMI and fat mass was present at baseline in subgroup D (r=0.8667, P=0.0000) but not in subgroup ND (r=0.3929, P=0.3833).
In subgroup D, the reduction in BMI was significantly related with fat mass (r=0.6072, P=0.005), but the same could not be affirmed for patients of the ND subgroup (Tables 4 and 5 ).
Discussion
In agreement with other findings, 5, 6 we found a high prevalence (73%) of patients with depressive symptoms at baseline in our COPD subjects that showed a significant decrease at the end of the rehabilitation program (7.7%). Previous reviews on pulmonary rehabilitation have indicated that 4-week programs can improve fatigue and emotional function, but these reviews included trials that did not specifically address effects on anxiety and depression, 36, 46 while in our results, the mean HAM-D scores (used in our research to divide the whole population into the two subgroups and for the evaluation of the changes of depressive symptoms) decreased significantly both in the total sample and in the D and ND subgroups. Another study examined the relationship between depression and aerobic exercise in generic chronic illness patients; 47 some others found a correlation between depression and/or anxiety and aerobic exercise in COPD patients undergoing pulmonary rehabilitation, but they did not investigate variables such as BMI or obesity. 36, [48] [49] [50] [51] Moreover, in our trial, all other assessed psychiatric (depression, anxiety, and cognitive function) and medical/ pneumological parameters demonstrated a significant improvement after the rehabilitation program.
The evaluation of cognitive performances, improved at 3 months, showed some peculiarities: the improvement in visual-spatial attention (TMT-A), although significant, was modest if compared with the TMT-B parameter, which assesses attention shifting ability and visual-spatial attention, as summarized by TMT-BA that represents the difference between the times of part B and those of part A in executive functioning (Table 1) .
Memory, assessed by RAVLT, was significantly enhanced at 3 months both in immediate and in deferred recall (Table 1) , such as praxic skills, mental representation, and planning (assessed by CDT) and deduction skills (evaluated through CPM) ( Table 1) . Table 4 Correlation analysis of the difference in psychometric and pneumological parameters, observed at baseline and at 3 months in the subgroup (n=38) of depression-positive subjects with COPD in a pulmonary rehabilitation program Table 5 Correlation analysis of the difference in psychometric and pneumological parameters, observed at baseline and at 3 months in the subgroup (n=14) of depression-negative subjects with COPD in a pulmonary rehabilitation program 
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Depression, BMI, and COPD We highlight the interesting correlations among STAI-1, MRC, and BODE (BMI, obstruction, dyspnea, exercise capacity) index: decrease in anxiety correlated with the improvement of dyspnea (MRC) and BODE index in the absence of correlation with objective indices such as forced expiratory volume in the 1st second, BMI, and 6MWT; this fact could be explained by the tendency of anxious depressed patients to amplify dyspnea. 52 The improvement in psychological parameters (anxiety and depressive symptoms, QoL, and cognitive performances) was related to a general decrease of fat mass and BMI in the total sample (Tables 4 and 5 ). In subgroup D, this correlation was particularly evident between BMI and the following psychometric variables: HADS-A, HADS-D, SCL-90, STAI-2, TMT-A, TMT-B, RAVLT, and CPM (Table 4) . Despite the general decrease of fat mass and BMI in the total sample, it was not statistically significant in subgroup ND, for which, unlike subgroup D (Table 5) , there was no correlation between BMI and fat mass, both at baseline and after the rehabilitation program. In this sense, BMI alone could be insufficient to explain the correlation with psychopathological parameters.
The different results observed between the two subgroups could be explained by the fact that D-subgroup patients presented a baseline condition of "overweight" and a higher fat mass percentage, not recorded in the ND subgroup, which was mainly composed of persons of normal weight. The only factor that indeed correlated with the majority of psychometric parameters was BMI, but only in subgroup D, where we recorded a correlation between BMI and fat mass.
In spite of the interesting findings, at least three limitations must be considered. First, metabolic and neurobiological analysis (eg, inflammatory and oxidative markers) could explain the link between anxiety and depressive symptoms and internistic medical disorders, such as COPD, in order to define a new meaning and management of them, but in this study was not performed. Second, the lack of International Journal of COPD 2016:11 submit your manuscript | www.dovepress.com
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Catalfo et al muscle mass evaluation could influence depressive and anxious symptoms. 53 Third, our sample size was small. So further studies are needed to evaluate the link between psychopathological symptoms and COPD in terms of inflammatory and oxidative markers with specific measures of them and the impact of muscle wasting on depression and anxiety in this specific population and, at the end, to augment the power of statistical analysis.
Conclusion
Our results suggest that it might be useful, in the context of multiple chronic diseases, to start a specific rehabilitation program (eg, of aerobic exercise) in order to establish a more appropriate and integrated therapeutic approach where there is suspicion, that needs to be confirmed, that a condition of increased adiposity could influence the genesis and evolution of psychiatric disorders.
